Explore more publications!

Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on December 5, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing
U.S. HDPE Conduit Market Trends: Rapid Growth at 5.6% CAGR Through 2033
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
Spyre Therapeutics Announces Grants of Inducement Awards
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Announcement relating to despatch of Rule 15 proposal
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Humanoid Global Welcomes Marc Theermann, Chief Strategy Officer of Boston Dynamics to its Technical Advisory Committee
MiLi Christmas Limited Edition — Christmas Gift Ideas That Shines Beyond the Holidays
Emerita Receives Official Court Resolution in Aznalcóllar Trial
Kingdom of Gaming to Land in Riyadh in December 2026
Black Hat MEA Wraps its Biggest Edition yet, Reinforcing Riyadh as the Region’s Cyber Control Room
Rosso Coffee Roasters selects Zoku’s Built for Netsuite Counter Service Solution
Message Central’s New VerifyNow OTP SDK Brings Instant, Secure Authentication to Any App
Evalyze Launches AI Investor Matching Engine to Help Startups Fundraise Faster

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions